Carbapenem resistance surges in HK: New IMPACT data underscore urgency
Antimicrobial resistance (AMR), particularly carbapenem-resistant Gram-negative bacteria (CR-GNB), continues to accelerate across Hong Kong, according to Reducing bacterial resistance with IMPACT (Interhospital Multi-disciplinary Programme on Antimicrobial ChemoTherapy), 6th edition, Hong Kong, published in 2025. This update provides new surveillance data and local clinical recommendations, and underscores the critical need for robust stewardship as CR-GNB infections emerge as a major threat to patient care.
